Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Nov 29;12(2):11154–11166. doi: 10.1080/21655979.2021.2005982

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 4. — MiR-200c-3p negatively regulates SERPINC1 in VTE rat models

(a) MiR-200 c-3p level in rat serum in control, thrombotic, thrombotic + NC, thrombotic + miR-200 c-3p inhibitor groups. n = 6. (b) SERPINC1 protein level in rat serum in each group. (c) Scatter plot analysis of the correlation between SERPINC1 protein level and miR-200 c-3p level in thrombotic rat serum. n = 18. (d) MiR-200 c-3p level in rat IVC in control, thrombotic, thrombotic + NC, thrombotic + miR-200 c-3p inhibitor groups. n = 6. (e) SERPINC1 protein level in IVC of rats in each group. (f) Scatter plot analysis of the correlation between SERPINC1 protein level and miR-200 c-3p expression in IVC of thrombotic rats. n = 18. **p < 0.01, ***p < 0.001. NC: miRNA inhibitor negative control.